Unlike high-grade serous ovarian cancer (HGSOC), which exhibits extensive genomic instability and nearly universal TP53 mutations, LGSOC harbors a much lower mutational burden and is genetically more stable [1]. The gene discussed is TP53; the disease is ovarian serous adenocarcinoma.